Challenges of accelerated vaccine development

Challenges of accelerated vaccine development

Show other versions (1)
Saved in:
Bibliographic Details
Other Authors: Simon, Jakub (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2020.
Series:Henry Stewart talks. Biomedical & life sciences collection.
Subjects:
Ebola virus disease > Prevention.
Vaccines > Development > Case studies.
Disease Outbreaks > prevention & control.
Drug Development.
Ebola Vaccines > supply & distribution.
Hemorrhagic Fever, Ebola > epidemiology.
Hemorrhagic Fever, Ebola > prevention & control.
Hemorrhagic Fever, Ebola > transmission.
Vaccines > supply & distribution.
Online Access:https://hstalks.com/bs/4276/
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000ngm a2200000 a 4500
001 HST5243
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 200604s2020 enk|||||||||||s|||v|eng d
028 5 0 |a 5243  |b Henry Stewart Talks 
035 |a (UkLoHST)4276 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Simon, Jakub,  |u (Director of Clinical Research, Vaccines, Merck Research Laboratories, USA)  |4 spk  |9 89402 
245 1 0 |a Challenges of accelerated vaccine development  |h [electronic resource] /  |c Jakub Simon. 
260 |a London :  |b Henry Stewart Talks,  |c 2020. 
300 |a 1 online resource (1 streaming video file (41 min.) :  |b color, sound). 
490 1 |a The biomedical & life sciences collection,  |x 2056-452X 
500 |a Animated audio-visual presentation with synchronized narration. 
500 |a Title from title frames. 
505 0 |a Contents: Vaccine development under normal circumstances -- Ebola: virus transmission, disease and outbreaks -- Ebola as a case-study for challenges of accelerated vaccine development -- Demonstrating safety, efficacy, and manufacturing consistency -- Challenges in cutting clinical development from 10+ to 5 years -- Vaccine acceleration can be achieved through good partnership. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Ebola virus disease  |x Prevention.  |9 89403 
650 0 |a Vaccines  |x Development  |v Case studies.  |9 89404 
650 2 |a Disease Outbreaks  |x prevention & control.  |9 89405 
650 2 |a Drug Development.  |9 89406 
650 2 |a Ebola Vaccines  |x supply & distribution.  |9 89407 
650 2 |a Hemorrhagic Fever, Ebola  |x epidemiology.  |9 89408 
650 2 |a Hemorrhagic Fever, Ebola  |x prevention & control.  |9 89409 
650 2 |a Hemorrhagic Fever, Ebola  |x transmission.  |9 89410 
650 2 |a Vaccines  |x supply & distribution.  |9 89411 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.   |9 89412 
856 4 0 |u https://hstalks.com/bs/4276/ 
999 |c 214037  |d 214036 

Similar Items